Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TSRO | TESARO, Inc. | -0.27% | 73.46 | 14.4% | $569.48m | |
| AMGN | Amgen Inc. | -1.57% | 187.10 | 1.2% | $545.46m | |
| GILD | Gilead Sciences, Inc. | -0.43% | 64.84 | 0.9% | $536.21m | |
| CELG | Celgene Corporation | -2.20% | 66.63 | 1.2% | $484.48m | |
| BIIB | Biogen Inc. | -5.86% | 294.75 | 1.3% | $368.52m | |
| ILMN | Illumina, Inc. | 0.87% | 313.58 | 3.5% | $340.51m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.73% | 369.00 | 2.6% | $264.69m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.65% | 163.43 | 1.9% | $212.48m | |
| A | Agilent Technologies, Inc. | 0.22% | 68.00 | 1.5% | $210.52m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -3.23% | 105.99 | 2.0% | $152.62m | |
| INCY | Incyte Corporation | -0.86% | 64.26 | 2.5% | $97.13m | |
| EXAS | Exact Sciences Corporation | 1.03% | 67.80 | 25.3% | $97.02m | |
| BLUE | Bluebird Bio, Inc. | -1.09% | 103.43 | 14.4% | $90.69m | |
| SRPT | Sarepta Therapeutics, Inc. | -6.64% | 108.02 | 15.4% | $84.06m | |
| NKTR | Nektar Therapeutics | 4.63% | 35.74 | 5.5% | $83.18m |
Company Profile
bluebird bio, Inc. is a clinical-stage biotechnology company. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. It offers the LentiGlobin which is a treatment for transfusion-dependent ß-thalassemia; and Lenti-D as a treatment for cerebral adrenoleukodystrophy. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.